Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms

By Brenner Annette K.   Reikvam Håkon   Lavecchia Antonio   Bruserud Øystein  

Molecules, Vol. 19, Iss. 11, 2014-11 ,pp. : 18414-18447

MDPI

Access to resources Recommend Favorite

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia

By Polillo Marialuisa   Galimberti Sara   Baratè Claudia   Petrini Mario   Danesi Romano   Di Paolo Antonello  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 22811-22829

MDPI

Access to resources Recommend Favorite

Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism

By Nepstad Ina   Reikvam Håkon   Brenner Annette K.   Bruserud Øystein   Hatfield Kimberley J.  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 382-382

MDPI

Access to resources Recommend Favorite

Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs

By Zebisch Armin   Hatzl Stefan   Pichler Martin   Wölfler Albert   Sill Heinz  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2080-2080

MDPI

Access to resources Recommend Favorite

The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia

By Johansen Silje   Brenner Annette K.   Bartaula-Brevik Sushma   Reikvam Håkon   Bruserud Øystein  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 251-251

MDPI

Access to resources Recommend Favorite